Filed
Proposal urging the Board of Directors to report to shareholders describing the governance measures Walmart has implemented since 2012 to more effectively monitor and manage financial and reputational risks related to the opioid crisis, including any changes in how the board oversees opioid-related matters, how incentive compensation for senior executives is determined, and how the board obtains input regarding opioids from stakeholders.
We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for other purposes. You can consent to the use of such technologies by using the “Accept” button, by closing this notice, by scrolling this page, by interacting with any link or button outside of this notice or by continuing to browse otherwise.